Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 575-584

  Green, Amity ^a   Ellis, Kathryn A ^b   Ellis, Julia ^a   Bartholomeusz, Cali F ^b   Ilic, Susan ^b   Croft, Rodney J ^b   Phan, K Luan ^c   Nathan, Pradeep J ^a  

^a MONASH UNIVERSITY   (Australia)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c The University of Chicago   (United States)

Author keywords

Cholinergic system; Cognitions; Copolamine; Mecamylamine; Muscarinic receptors; Nicotinic receptors n back; Schizophrenia; Working memory

Indexed keywords

MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PLACEBO; SCOPOLAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HUMAN; HUMAN EXPERIMENT; INHIBITION KINETICS; MALE; MEMORY DISORDER; METHODOLOGY; NORMAL HUMAN; PERFORMANCE; PRIORITY JOURNAL; SPATIAL MEMORY; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; WORKING MEMORY;

ADULT; ANALYSIS OF VARIANCE; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MECAMYLAMINE; MEMORY, SHORT-TERM; MUSCARINIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; NICOTINIC ANTAGONISTS; PLACEBOS; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; REPRODUCIBILITY OF RESULTS; SCOPOLAMINE;

EID: 22044440986     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.04.010     Document Type: Article

References (86)

1. A. Abi-Dargham, O. Mawlawi, I. Lombardo, R. Gil, D. Martinez, and Y. Huang Prefrontal dopamine D-1 receptors and working memory in schizophrenia J Neurosci 22 2002 3708 3719
2. A.F. Arnsten, and P.S. Goldman-Rakic Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism Arch Gen Psychiatry 55 1998 362 368
3. A.F. Arnsten, J.X. Cai, B.L. Murphy, and PS. Goldman-Rakic Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys Psychopharmacology 116 1994 143 151
4. D.M. Barch, C.S. Carter, T.S. Braver, F.W. Sabb, A. MacDonald, and D.C. Noll Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia Arch Gen Psychiatry 58 2001 280 288
5. C.F. Bartholomeusz, G. Box, C. Van Rooy, and P.J. Nathan The modulatory effects of dopamine D-1 and D-2 receptor function on object working memory in humans J Psychopharmacol 17 2003 9 15
6. R.T. Bartus, R.L Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
7. T.S. Braver, J.D. Cohen, L.E. Nystrom, J. Jonides, E.E. Smith, and D.C. Noll A parametric study of prefrontal cortex involvement in human working memory Neuroimage 5 1997 49 62
8. C.R. Breese, M.J. Lee, C.E. Adams, B. Sullivan, J. Logel, and K.M. Gillen Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia Neuropsychopharmacology 23 2000 351 364
9. P. Broks, G.C. Preston, M. Traub, P. Poppleton, C. Ward, and M. Stahl Modelling dementia: effects of scopolamine on memory and attention Neuropsychologia 26 1988 685 700
10. J.H. Brown Atropine, scopolamine, and related antimuscarinic drugs Gilman A. Goodman T.W. Rall A.S. Nies P. Taylor The pharmacological basis of therapeutics 1992 McGraw-Hill International Editions Singapore 150 166
11. E.N. Brown, and J.J. Galligan Muscarinic receptors couple to modulation of nicotinic ACh receptor desensitization in myenteric neurons Am J Physiol Gastrointest Liver Physiol 285 2003 G37 G44
12. J.H. Callicott, A. Bertolino, V.S. Mattay, F.J. Langheim, J. Duyn, and R. Coppola Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited Cereb Cortex 10 2000 1078 1092
13. C.S. Carter, W. Perlstein, R. Ganguli, J. Brar, M. Mintun, and J.D. Cohen Functional hypofrontality and working memory dysfunction in schizophrenia Am J Psychiatry 155 1998 1285 1287
14. J.D. Cohen, S. Forman, T. Braver, B. Casey, D. Servan-Schreiber, and D. Noll Activation of the prefrontal cortex in a non-spatial working memory task with functional MRI Hum Brain Map 1 1994 293 304
15. J.D. Cohen, W.M. Perlstein, T.S. Braver, L.E. Nystrom, D.C. Noll, and J. Jonides Temporal dynamics of brain activation during a working memory task Nature 386 1997 604 608
16. F. Collette, and M. Van der Linden Brain imaging of the central executive component of working memory Neurosci Biobehav Rev 26 2002 105 125
17. H.M. Conklin, C.E. Curtis, J. Katsanis, and W.G. Iocono Verbal working memory impairment in schizophrenia patients and their first-degree relatives: evidence from the digit span task Am J Psychiatry 157 2 2000 275 277
18. J.M. Crook, E. Tomaskovic-Crook, D.L. Copolov, and B. Dean Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation Biol Psychiatry 48 2000 381 388
19. J.M. Crook, E. Tomaskovic-Crook, D.L. Copolov, and B. Dean Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment Am J Psychiatry 158 2001 918 925
20. J.W. Dalley, D.E. Theobald, P. Bouger, Y. Chudasama, R.N. Cardinal, and T.W. Robbins Cortical cholinergic function and deficits in visual attentional performance in rats following 192 IgG-saporin-induced lesions of the medial prefrontal cortex Cereb Cortex 14 2004 922 932
21. B. Dean, J.M. Crook, K. Opeskin, C. Hill, N. Keks, and D.L. Copolov The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia Mol Psychiatry 1 1996 54 58
22. M. D'Esposito, D. Ballard, G.K. Aguirre, and E. Zarahn Human prefrontal cortex is not specific for working memory: a functional MRI study Neuroimage 8 3 1998 274 282
23. U. Ebert, R. Oertel, K.A. Wesnes, and W. Kirch Effects of physostigmine on scopolamine-induced changes in quantitative electroencephalogram and cognitive performance Hum Psychopharmacol 13 1998 199 210
24. T. Edginton, and J.M. Rusted Separate and combined effects of scopolamine and nicotine on retrieval-induced forgetting Psychopharmacology 170 2003 351 357
25. K.A. Ellis, and P.J. Nathan The pharmacology of human working memory Int J Neuropsychopharmacol 4 2001 299 313
26. J.R. Ellis, K.A. Ellis, C.F. Bartholomeusz, B.J. Harrison, K.A. Wesnes, and F.F. Erskine Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans Int J Neuropsychopharmacol 9 2005 1 15 [Epub ahead of print]
27. F.F. Erskine, J.R. Ellis, K.A. Ellis, E. Stuber, K. Hogan, and V. Miller Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans Hum Psychopharmacol 19 2004 503 509
28. K. Fleming, T.E. Goldberg, J.M. Gold, and D.R. Weinberger Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm Psychiatry Res 56 2 1995 155 161
29. R. Freedman, M. Hall, L.E. Adler, and S. Leonard Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia Biol Psychiatry 38 1995 22 33
30. T.P. George, J.C. Vessicchio, A. Termine, D.M. Sahady, C.A. Head, and W.T. Pepper Effects of smoking abstinence on visuospatial working memory function in schizophrenia Neuropsychopharmacology 26 2002 75 85
31. T.E. Goldberg, M.F. Egan, T. Gscheidle, R. Coppola, T. Weickert, and B.S. Kolachana Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia Arch Gen Psychiatry 60 2003 889 896
32. P.S. Goldman-Rakic Working memory dysfunction in schizophrenia J Neuropsychiatry Clin Neurosci 6 1994 348 357
33. P.S. Goldman-Rakic, E.C. Muly, and G.V. Williams D-1 receptors in prefrontal cells and circuits Brain Res Rev 31 2000 295 301
34. P.S. Goldman-Rakic, S.A. Castner, T.H. Svensson, L.J. Siever, and G.V. Williams Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction Psychopharmacology 174 2004 3 16
35. S. Granon, B. Poucet, C. Thinus-Blanc, J.P. Changeux, and C. Vidal Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing Psychopharmacology 119 2 1995 139 144
36. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321 330
37. Z.Z. Guan, X. Zhang, K. Blennow, and A. Nordberg Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain NeuroReport 10 1999 1779 1782
38. I. Hindmarch, and A.C. Parrott Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance Br J Clin Pharmacol 4 Suppl 2 1977 167S 173S
39. G.D. Honey, E.T. Bullmore, and T. Sharma De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia Schizophr Res 53 2002 45 56
40. J. Ichikawa, J. Dai, I.A. O'Laughlin, W.L. Fowler, and H.Y. Meltzer Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum Neuropsychopharmacology 26 2002 325 339
41. L.K. Jacobsen, C.D. D'Souza, W. Einar Mencl, K.R. Pugh, P. Skudlarski, and J.H. Krystal Nicotine effects on brain function and functional connectivity in schizophrenia Biol Psychiatry 55 2004 850 858
42. J.M. Jansma, N.F. Ramsey, R. Coppola, and R.S. Kahn Specific versus nonspecific brain activity in a parametric N-back task Neuroimage 12 2000 688 697
43. J. Jonides, E.H. Schumacher, E.E. Smith, E.J. Lauber, E. Awh, and S. Minoshima Verbal working memory load affects regional brain activation as measured by PET J Cogn Neurosci 9 1997 462 475
44. Z. Katerina, K. Andrew, M. Filomena, and H. Xu-Feng Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder Neuropsychopharmacology 29 2004 619 625
45. R.S. Keefe, S.E. Lees-Roitman, and R.L. Dupre Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay Schizophr Res 26 1 1997 9 14
46. R.M. Kirrane, V. Mitropoulou, M. Nunn, J. Silverman, and L.J. Siever Physostigmine and cognition in schizotypal personality disorder Schizophr Res 48 2001 1 5
47. M.D. Kopelman, and T.H. Corn Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome Brain 111 1988 1079 1110
48. V. Kumari, J. Gray, D.H. Ffytche, M.T. Mitterschiithaler, M. Das, and E. Zachariah Cognitive effects of nicotine in humans: an fMRI study Neuroimage 19 2003 1002 1013
49. L. Leblond, C. Beaufort, F. Delerue, and T.P. Durkin Differential roles for nicotinic and muscarinic cholinergic receptors in sustained visuo-spatial attention? A study using a 5-arm maze protocol in mice Behav Brain Res 128 1 2002 91 102
50. E.D. Levin, J.E. Rose, S.R. McGurk, and L.L. Butcher Characterization of the cognitive effects of combined muscarinic and nicotinic blockade Behav Neural Biol 53 1990 103 112
51. E.D. Levin, S.J. Briggs, N.C. Christopher, and J.E. Rose Chronic nicotinic stimulation and blockade effects on working memory Behav Pharmacol 4 1993 179 182
52. E.D. Levin, S. Kaplan, and A. Boardman Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze Behav Pharmacol 8 1997 236 242
53. P.F. Liddle Cognitive impairment in schizophrenia: its impact on social functioning Acta Psychiatr Scand Suppl 400 2000 11 16
54. J.T. Little, D.N. Johnson, M. Minichiello, H. Weingartner, and T. Sunderland Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioral, and physiologic responses Neuropsychopharmacology 19 1998 60 69
55. M. Luciana, P.F. Collins, and R.A. Depue Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions Cereb Cortex 8 1998 218 226
56. T. Maviel, and T.P. Durkin Role of central cholinergic receptor sub-types in spatial working memory: a five-arm maze task in mice provides evidence for a functional role of nicotinic receptors in mediating trace access processes Neuroscience 120 2003 1049 1059
57. M.A. Mehta, B.J. Sahakian, P.J. McKenna, and T.W. Robbins Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease Psychopharmacology 146 1999 162 174
58. H.Y. Meltzer, and S.R. McGurk The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizophr Bull 25 1999 233 255
59. S.P. Mewaldt, and M.M. Ghoneim The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory Pharmacol Biochem Behav 10 1979 205 210
60. N.R. Mirza, and I.P. Stolerman The role of nicotinic and muscarinic acetylcholine receptors in attention Psychopharmacology 148 2000 243 250
61. U. Muller, D.Y. von Cramon, and S. Pollmann D1- versus D2-receptor modulation of visuospatial working memory in humans J Neurosci 18 1998 2720 2728
62. P.A. Newhouse, A. Potter, J. Corwin, and R. Lenox Acute nicotinic blockade produces cognitive impairment in normal humans Psychopharmacology 108 1992 480 484
63. P.A. Newhouse, A. Potter, J. Corwin, and R. Lennox Age-related effects of the nicotinic antagonist mecamylamine on cognition and behaviour Neuropsychopharmacology 10 1994 93 107
64. S. Park, and P.S. Holzman Schizophrenics show spatial working memory deficits Arch Gen Psychiatry 49 12 1992 975 982
65. W.M. Perlstein, C.S. Carter, D.C. Noll, and J.D. Cohen Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia Am J Psychiatry 158 2001 1105 1113
66. E.K. Perry, B.E. Tomlinson, G. Blessed, K. Bergmann, P.H. Gibson, and R.H. Perry Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia Br Med J 2 1978 1457 1459
67. W.B. Pickworth, R.V. Fant, M.F. Butschky, and J.E. Henningfield Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers Pharmacol Biochem Behav 56 1997 181 187
68. D.D. Potter, C.D. Pickles, R.C. Roberts, and M.D. Rugg The effect of cholinergic receptor blockade by scopolamine on memory performance and the auditory P3 Psychophysiology 14 2000 11 23
69. T.J. Raedler, M.B. Knable, D.W. Jones, R.A. Urbina, J.G. Gorey, and K.S. Lee In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia Am J Psychiatry 160 2003 118 127
70. D.D. Rasmusson, and J.D. Dudar Effect of scopolamine on maze learning performance in humans Experientia 35 1979 1069 1070
71. P. Riekkinen Jr., M. Riekkinen, and J. Sirvio Cholinergic drugs regulate passive avoidance performance via the amygdala J Pharmacol Exp Ther 267 3 1993 1484 1492
72. T.W. Robbins, J. Semple, R. Kumar, M.I. Truman, J. Shorter, and A. Ferraro Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia Psychopharmacology 134 1997 95 106
73. J.M. Rusted, and D.M. Warburton The effects of scopolamine on working memory in healthy young volunteers Psychopharmacology 96 1988 145 152
74. J.M. Rusted, P. Eaton-Williams, and D.M. Warburton A comparison of the effects of scopolamine and diazepam on working memory Psychopharmacology 105 1991 442 445
75. D.J. Safer, and R.P. Allen The central effects of scopolamine in man Biol Psychiatry 3 1971 347 355
76. M. Sarter, and J.P. Bruno Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders Trends Neurosci 22 1999 67 74
77. T. Sawaguchi, and P.S. Goldman-Rakic D1 dopamine receptors in prefrontal cortex: involvement in working memory Science 251 1991 947 950
78. T. Sawaguchi, and P.S. Goldman-Rakic The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task J Neurophysiol 71 1994 515 528
79. S. Shirazi-Southall, D.E. Rodriguez, and G.G. Nomikos Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat Neuropsychopharmacology 26 2002 583 594
80. B.G. Tabachnick, and L.S. Fidell Using multivariate statistics 2nd ed. 1989 Harper Collins Northridge, CA
81. J.C. Thompson, C. Stough, D. Ames, C. Ritchie, and P.J. Nathan Effects of the nicotinic antagonist mecamylamine on inspection time Psychopharmacology 150 2000 117 119
82. W. Varanda, Y. Aracava, S.M. Sherby, W.G. Vanmeter, M.E. Eldefrawi, and E.X. Albuquerquem The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a non-competitive antagonist Mol Pharmacol 28 1985 128 137
83. X. Vige, and M. Briley Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats Neurosci Lett 88 1988 319 324
84. K.A. Wesnes, P.M. Simpson, and A.G. Kidd An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg s.c. Hum Psychopharmacol 3 1988 27 41
85. J.M. Young, R.D. Shytle, P.R. Sanberg, and T.P. George Mecamylamine: new therapeutic uses and toxicity/risk profile Clin Ther 23 2001 532 565
86. B. Zurowski, J. Gostomzyk, G. Gron, R. Weller, H. Schirrmeister, and B. Neumeier Dissociating a common working memory network from different neural substrates of phonological and spatial stimulus processing Neuroimage 15 2002 45 57